{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:07:00Z","timestamp":1791389220260,"version":"4.3.3"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T00:00:00Z","timestamp":1732665600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T00:00:00Z","timestamp":1732665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Beijing Bethune Charitable Foundation","award":["BJ-GY2021004J"],"award-info":[{"award-number":["BJ-GY2021004J"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070929"],"award-info":[{"award-number":["82070929"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"DOI":"10.1186\/s12886-024-03771-5","type":"journal-article","created":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T13:18:52Z","timestamp":1732713532000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Comparison of therapeutic effects of 0.05% Cyclosporine A versus 0.1% Fluorometholone in Chinese patients with mild dry eye unresponsive to artificial tears: a randomized control study"],"prefix":"10.1186","volume":"24","author":[{"given":"Huijuan","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aoxue","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengdi","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel Eric","family":"Pazo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruihua","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,27]]},"reference":[{"key":"3771_CR1","doi-asserted-by":"publisher","first-page":"106206","DOI":"10.1016\/j.ejps.2022.106206","volume":"175","author":"HB Mohamed","year":"2022","unstructured":"Mohamed HB, Abd El-Hamid BN, Fathalla D, Fouad EA. Current trends in pharmaceutical treatment of dry eye disease: a review. Eur J Pharm Sciences: Official J Eur Federation Pharm Sci. 2022;175:106206.","journal-title":"Eur J Pharm Sciences: Official J Eur Federation Pharm Sci"},{"issue":"3","key":"3771_CR2","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1097\/ICU.0000000000000569","volume":"30","author":"EC O\u2019Neil","year":"2019","unstructured":"O\u2019Neil EC, Henderson M, Massaro-Giordano M, Bunya VY. Advances in dry eye disease treatment. Curr Opin Ophthalmol. 2019;30(3):166\u201378.","journal-title":"Curr Opin Ophthalmol"},{"issue":"3","key":"3771_CR3","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.jtos.2017.05.003","volume":"15","author":"F Stapleton","year":"2017","unstructured":"Stapleton F, Alves M, Bunya VY, Jalbert I, Lekhanont K, Malet F, Na KS, Schaumberg D, Uchino M, Vehof J, et al. TFOS DEWS II Epidemiology Report. Ocul Surf. 2017;15(3):334\u201365.","journal-title":"Ocul Surf"},{"key":"3771_CR4","doi-asserted-by":"crossref","unstructured":"Zhang X, Qu MVJ, He Y, Ou X, Bu S, Jia J, Wang C, Wu J, Liu H. Z Dry Eye Management: targeting the Ocular Surface Microenvironment. Int J Mol Sci 2017; 18(7).","DOI":"10.3390\/ijms18071398"},{"key":"3771_CR5","doi-asserted-by":"publisher","first-page":"732887","DOI":"10.3389\/fphar.2021.732887","volume":"12","author":"L Yu","year":"2021","unstructured":"Yu L, Yu C, Dong H, Mu Y, Zhang R, Zhang Q, Liang W, Li W, Wang X, Zhang L. Recent developments about the pathogenesis of Dry Eye Disease: based on Immune Inflammatory mechanisms. Front Pharmacol. 2021;12:732887.","journal-title":"Front Pharmacol"},{"issue":"4","key":"3771_CR6","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.4103\/IJO.IJO_2981_22","volume":"71","author":"NR Kumar","year":"2023","unstructured":"Kumar NR, Praveen M, Narasimhan R, Khamar P, D\u2019Souza S, Sinha-Roy A, Sethu S, Shetty R, Ghosh A. Tear biomarkers in dry eye disease: progress in the last decade. Indian J Ophthalmol. 2023;71(4):1190\u2013202.","journal-title":"Indian J Ophthalmol"},{"key":"3771_CR7","doi-asserted-by":"publisher","first-page":"107420","DOI":"10.1016\/j.intimp.2021.107420","volume":"93","author":"Q Gui","year":"2021","unstructured":"Gui Q, Jiang Z, Zhang L. Insights into the modulatory role of cyclosporine A and its research advances in acute inflammation. Int Immunopharmacol. 2021;93:107420.","journal-title":"Int Immunopharmacol"},{"key":"3771_CR8","doi-asserted-by":"publisher","first-page":"109892","DOI":"10.1016\/j.vetimm.2019.109892","volume":"216","author":"CL Fellman","year":"2019","unstructured":"Fellman CL, Archer TM, Wills RW, Mackin AJ. Effects of cyclosporine and dexamethasone on canine T cell expression of interleukin-2 and interferon-gamma. Vet Immunol Immunopathol. 2019;216:109892.","journal-title":"Vet Immunol Immunopathol"},{"key":"3771_CR9","doi-asserted-by":"publisher","first-page":"3183","DOI":"10.2147\/DDDT.S370559","volume":"16","author":"W Peng","year":"2022","unstructured":"Peng W, Jiang X, Zhu L, Li X, Zhou Q, Jie Y, You Z, Wu M, Jin X, Li X, et al. Cyclosporine A (0.05%) Ophthalmic Gel in the treatment of Dry Eye Disease: a Multicenter, Randomized, Double-Masked, phase III, COSMO Trial. Drug Des Devel Ther. 2022;16:3183\u201394.","journal-title":"Drug Des Devel Ther"},{"issue":"9","key":"3771_CR10","first-page":"Cd010051","volume":"9","author":"CS de Paiva","year":"2019","unstructured":"de Paiva CS, Pflugfelder SC, Ng SM, Akpek EK. Topical cyclosporine A therapy for dry eye syndrome. Cochrane Database Syst Rev. 2019;9(9):Cd010051.","journal-title":"Cochrane Database Syst Rev"},{"key":"3771_CR11","doi-asserted-by":"crossref","unstructured":"Labetoulle M, Benitez-Del-Castillo JM, Barabino S, Herrero Vanrell R, Daull P, Garrigue JS, Rolando M. Artificial tears: Biological Role of their ingredients in the management of Dry Eye Disease. Int J Mol Sci 2022; 23(5).","DOI":"10.3390\/ijms23052434"},{"key":"3771_CR12","unstructured":"Consensus of Chinese experts on dry eye: examination and diagnosis. (2020). Chin J Ophthalmol. 2020; 56(10):7."},{"key":"3771_CR13","unstructured":"Consensus of Chinese dry eye Experts: definition and classification. (2020). Chin J Ophthalmol. 2020; 56(6)."},{"issue":"5","key":"3771_CR14","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1097\/ICO.0b013e3182714425","volume":"32","author":"J Hong","year":"2013","unstructured":"Hong J, Sun X, Wei A, Cui X, Li Y, Qian T, Wang W, Xu J. Assessment of tear film stability in dry eye with a newly developed keratograph. Cornea. 2013;32(5):716\u201321.","journal-title":"Cornea"},{"issue":"4","key":"3771_CR15","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/S0161-6420(99)90170-7","volume":"106","author":"AA Afonso","year":"1999","unstructured":"Afonso AA, Monroy D, Stern ME, Feuer WJ, Tseng SC, Pflugfelder SC. Correlation of tear fluorescein clearance and Schirmer test scores with ocular irritation symptoms. Ophthalmology. 1999;106(4):803\u201310.","journal-title":"Ophthalmology"},{"issue":"3","key":"3771_CR16","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.jtos.2017.05.001","volume":"15","author":"JS Wolffsohn","year":"2017","unstructured":"Wolffsohn JS, Arita R, Chalmers R, Djalilian A, Dogru M, Dumbleton K, Gupta PK, Karpecki P, Lazreg S, Pult H, et al. TFOS DEWS II Diagnostic Methodology report. Ocul Surf. 2017;15(3):539\u201374.","journal-title":"Ocul Surf"},{"issue":"6","key":"3771_CR17","doi-asserted-by":"publisher","first-page":"834","DOI":"10.18240\/ijo.2021.06.07","volume":"14","author":"XM Zhang","year":"2021","unstructured":"Zhang XM, Yang LT, Zhang Q, Fan QX, Zhang C, You Y, Zhang CG, Lin TZ, Xu L, Moutari S, et al. Reliability of Chinese web-based ocular surface disease index questionnaire in dry eye patients: a randomized, crossover study. Int J Ophthalmol. 2021;14(6):834\u201343.","journal-title":"Int J Ophthalmol"},{"issue":"4","key":"3771_CR18","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1109\/TBME.2016.2573642","volume":"64","author":"X Chen","year":"2017","unstructured":"Chen X, Graham J, Dabbah MA, Petropoulos IN, Tavakoli M, Malik RA. An Automatic Tool for quantification of nerve fibers in corneal confocal Microscopy images. IEEE Trans Bio Med Eng. 2017;64(4):786\u201394.","journal-title":"IEEE Trans Bio Med Eng"},{"key":"3771_CR19","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.preteyeres.2016.04.005","volume":"54","author":"IK Gipson","year":"2016","unstructured":"Gipson IK. Goblet cells of the conjunctiva: a review of recent findings. Prog Retin Eye Res. 2016;54:49\u201363.","journal-title":"Prog Retin Eye Res"},{"issue":"1","key":"3771_CR20","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.ophtha.2015.09.029","volume":"123","author":"J Pinto-Fraga","year":"2016","unstructured":"Pinto-Fraga J, L\u00f3pez-Miguel A, Gonz\u00e1lez-Garc\u00eda MJ, Fern\u00e1ndez I, L\u00f3pez-de-la-Rosa A, Enr\u00edquez-de-Salamanca A, Stern ME, Calonge M. Topical Fluorometholone protects the ocular surface of Dry Eye patients from desiccating stress: a Randomized Controlled Clinical Trial. Ophthalmology. 2016;123(1):141\u201353.","journal-title":"Ophthalmology"},{"issue":"1","key":"3771_CR21","doi-asserted-by":"publisher","first-page":"68","DOI":"10.4103\/tjo.TJO-D-22-00140","volume":"13","author":"YH Chan","year":"2023","unstructured":"Chan YH, Sun CC. Efficacy and safety of topical cyclosporine 0.1% in moderate-to-severe dry eye disease refractory to topical cyclosporine 0.05% regimen. Taiwan J Ophthalmol. 2023;13(1):68\u201374.","journal-title":"Taiwan J Ophthalmol"},{"issue":"2","key":"3771_CR22","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1089\/jop.2022.0133","volume":"39","author":"VL Perez","year":"2023","unstructured":"Perez VL, Mah FS, Willcox M, Pflugfelder S. Anti-inflammatories in the treatment of Dry Eye Disease: a review. J Ocular Pharmacol Therapeutics: Official J Association Ocular Pharmacol Ther. 2023;39(2):89\u2013101.","journal-title":"J Ocular Pharmacol Therapeutics: Official J Association Ocular Pharmacol Ther"},{"issue":"1","key":"3771_CR23","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4103\/2211-5056.369606","volume":"13","author":"A Nguyen","year":"2023","unstructured":"Nguyen A, Kolluru A, Beglarian T. Dry eye disease: a review of anti-inflammatory therapies. Taiwan J Ophthalmol. 2023;13(1):3\u201312.","journal-title":"Taiwan J Ophthalmol"},{"issue":"3","key":"3771_CR24","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1097\/ICO.0b013e31802dffc7","volume":"26","author":"SE Wilson","year":"2007","unstructured":"Wilson SE, Stulting RD. Agreement of physician treatment practices with the international task force guidelines for diagnosis and treatment of dry eye disease. Cornea. 2007;26(3):284\u20139.","journal-title":"Cornea"},{"issue":"2","key":"3771_CR25","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3341\/kjo.2014.28.2.115","volume":"28","author":"JS Song","year":"2014","unstructured":"Song JS, Hyon JY, Lee D, Chung E, Choi C, Lee J, Kim HM. Current practice pattern for dry eye patients in South Korea: a multicenter study. Korean J Ophthalmology: KJO. 2014;28(2):115\u201321.","journal-title":"Korean J Ophthalmology: KJO"},{"issue":"5","key":"3771_CR26","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/S0161-6420(00)00035-X","volume":"107","author":"D Stevenson","year":"2000","unstructured":"Stevenson D, Tauber J, Reis BL. Efficacy and safety of cyclosporin A ophthalmic emulsion in the treatment of moderate-to-severe dry eye disease: a dose-ranging, randomized trial. The cyclosporin a phase 2 Study Group. Ophthalmology. 2000;107(5):967\u201374.","journal-title":"Ophthalmology"},{"issue":"8","key":"3771_CR27","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1089\/jop.2020.0146","volume":"37","author":"J Kim","year":"2021","unstructured":"Kim J, Moon TK, Yoon HJ, Ji YS, Yoon KC. Efficacy of switching from Cyclosporine A 0.05% Anionic Emulsion to Cyclosporine A 0.1% Cationic Emulsion in patients with Dry Eye Associated with Sj\u00f6gren\u2019s syndrome. J Ocular Pharmacol Therapeutics: Official J Association Ocular Pharmacol Ther. 2021;37(8):472\u20138.","journal-title":"J Ocular Pharmacol Therapeutics: Official J Association Ocular Pharmacol Ther"},{"issue":"6","key":"3771_CR28","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1007\/s13346-019-00650-1","volume":"9","author":"D Patel","year":"2019","unstructured":"Patel D, Wairkar S. Recent advances in cyclosporine drug delivery: challenges and opportunities. Drug Delivery Translational Res. 2019;9(6):1067\u201381.","journal-title":"Drug Delivery Translational Res"},{"issue":"5","key":"3771_CR29","doi-asserted-by":"publisher","first-page":"352","DOI":"10.3109\/09273948.2010.498657","volume":"18","author":"CA Utine","year":"2010","unstructured":"Utine CA, Stern M, Akpek EK. Clinical review: topical ophthalmic use of cyclosporin A. Ocul Immunol Inflamm. 2010;18(5):352\u201361.","journal-title":"Ocul Immunol Inflamm"},{"issue":"10","key":"3771_CR30","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1097\/ICO.0000000000002633","volume":"40","author":"JD Sheppard","year":"2021","unstructured":"Sheppard JD, Wirta DL, McLaurin E, Boehmer BE, Ciolino JB, Meides AS, Schl\u00fcter T, Ousler GW, Usner D, Kr\u00f6sser S. A water-free 0.1% cyclosporine a solution for treatment of Dry Eye Disease: results of the Randomized Phase 2B\/3 ESSENCE Study. Cornea. 2021;40(10):1290\u20137.","journal-title":"Cornea"},{"issue":"5","key":"3771_CR31","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1001\/jamaophthalmol.2023.0709","volume":"141","author":"EK Akpek","year":"2023","unstructured":"Akpek EK, Wirta DL, Downing JE, Tauber J, Sheppard JD, Ciolino JB, Meides AS, Kr\u00f6sser S. Efficacy and safety of a water-free topical cyclosporine, 0.1%, solution for the treatment of moderate to severe Dry Eye Disease: the ESSENCE-2 Randomized Clinical Trial. JAMA Ophthalmol. 2023;141(5):459\u201366.","journal-title":"JAMA Ophthalmol"},{"issue":"3","key":"3771_CR32","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.jtos.2014.12.006","volume":"13","author":"KH Wan","year":"2015","unstructured":"Wan KH, Chen LJ, Young AL. Efficacy and safety of topical 0.05% Cyclosporine Eye drops in the treatment of Dry Eye Syndrome: a systematic review and Meta-analysis. Ocul Surf. 2015;13(3):213\u201325.","journal-title":"Ocul Surf"},{"issue":"8","key":"3771_CR33","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1056\/NEJM199302253280817","volume":"328","author":"K Tsubota","year":"1993","unstructured":"Tsubota K, Nakamori K. Dry eyes and video display terminals. N Engl J Med. 1993;328(8):584.","journal-title":"N Engl J Med"},{"key":"3771_CR34","doi-asserted-by":"crossref","unstructured":"Alryalat SA, Toubasi AA, Patnaik JL, Kahook MY. The impact of air pollution and climate change on eye health: a global review. Rev Environ Health 2022.","DOI":"10.1515\/reveh-2022-0209"},{"issue":"4","key":"3771_CR35","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1177\/112067211002000405","volume":"20","author":"B Y\u00fcksel","year":"2010","unstructured":"Y\u00fcksel B, Bozda\u011f B, Acar M, Topalo\u011flu E. Evaluation of the effect of topical cyclosporine A with impression cytology in dry eye patients. Eur J Ophthalmol. 2010;20(4):675\u20139.","journal-title":"Eur J Ophthalmol"},{"issue":"8","key":"3771_CR36","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1001\/archopht.126.8.1046","volume":"126","author":"HD Perry","year":"2008","unstructured":"Perry HD, Solomon R, Donnenfeld ED, Perry AR, Wittpenn JR, Greenman HE, Savage HE. Evaluation of topical cyclosporine for the treatment of dry eye disease. Archives Ophthalmol (Chicago Ill: 1960). 2008;126(8):1046\u201350.","journal-title":"Archives Ophthalmol (Chicago Ill: 1960)"},{"issue":"1","key":"3771_CR37","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jtos.2019.11.005","volume":"18","author":"SK Swamynathan","year":"2020","unstructured":"Swamynathan SK, Wells A. Conjunctival goblet cells: ocular surface functions, disorders that affect them, and the potential for their regeneration. Ocul Surf. 2020;18(1):19\u201326.","journal-title":"Ocul Surf"},{"key":"3771_CR38","doi-asserted-by":"crossref","unstructured":"Barbosa FL, Xiao Y, Bian F, Coursey TG, Ko BY, Clevers H, de Paiva CS, Pflugfelder SC. Goblet cells contribute to Ocular Surface Immune Tolerance-implications for Dry Eye Disease. Int J Mol Sci 2017; 18(5).","DOI":"10.3390\/ijms18050978"},{"issue":"2","key":"3771_CR39","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.ajo.2008.08.015","volume":"147","author":"EC Kim","year":"2009","unstructured":"Kim EC, Choi JS, Joo CK. A comparison of vitamin a and cyclosporine a 0.05% eye drops for treatment of dry eye syndrome. Am J Ophthalmol. 2009;147(2):206\u2013e213203.","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"3771_CR40","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.jtos.2019.12.006","volume":"18","author":"J Alam","year":"2020","unstructured":"Alam J, de Paiva CS, Pflugfelder SC. Immune - Goblet cell interaction in the conjunctiva. Ocul Surf. 2020;18(2):326\u201334.","journal-title":"Ocul Surf"},{"issue":"9","key":"3771_CR41","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1007\/s00417-017-3680-3","volume":"255","author":"TC Tepelus","year":"2017","unstructured":"Tepelus TC, Chiu GB, Huang J, Huang P, Sadda SR, Irvine J, Lee OL. Correlation between corneal innervation and inflammation evaluated with confocal microscopy and symptomatology in patients with dry eye syndromes: a preliminary study. Graefe\u2019s Archive Clin Experimental Ophthalmol = Albrecht Von Graefes Archiv fur Klinische und Experimentelle Ophthalmologie. 2017;255(9):1771\u20138.","journal-title":"Graefe\u2019s Archive Clin Experimental Ophthalmol = Albrecht Von Graefes Archiv fur Klinische und Experimentelle Ophthalmologie"},{"key":"3771_CR42","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.jtos.2020.05.012","volume":"19","author":"S Aggarwal","year":"2021","unstructured":"Aggarwal S, Kheirkhah A, Cavalcanti BM, Cruzat A, Jamali A, Hamrah P. Correlation of corneal immune cell changes with clinical severity in dry eye disease: an in vivo confocal microscopy study. Ocul Surf. 2021;19:183\u20139.","journal-title":"Ocul Surf"},{"issue":"5","key":"3771_CR43","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/ceo.12898","volume":"45","author":"O Levy","year":"2017","unstructured":"Levy O, Labb\u00e9 A, Borderie V, Hamiche T, Dupas B, Laroche L, Baudouin C, Bouheraoua N. Increased corneal sub-basal nerve density in patients with Sj\u00f6gren syndrome treated with topical cyclosporine A. Clin Exp Ophthalmol. 2017;45(5):455\u201363.","journal-title":"Clin Exp Ophthalmol"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-024-03771-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-024-03771-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-024-03771-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T14:05:14Z","timestamp":1732716314000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-024-03771-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,27]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3771"],"URL":"https:\/\/doi.org\/10.1186\/s12886-024-03771-5","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,27]]},"assertion":[{"value":"1 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research was approved by the Ethics Committee of Tianjin Medical University Eye Hospital (ethics approval number: 2021KY-17). Written informed consent was obtained from all enrolled participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"513"}}